- Tidingo.com

Michael Karin, Professor At UCSD To Give Keynote Speech At 7th Cytokines And Inflammation Conference

Michael Karin, Professor of Pharmacology Tumor Growth Invasion and Metastasis at UCSD to Give Keynote Speech at GTCbio's 7th Cytokines and Inflammation Conference on January 29-30, 2009 in San Diego, CA Dr.

Worst - 1

1
2
3
4
5

Best - 5

13.12.2008 09:00:00 - Health News from Medical News Today

Hard link

GTCbio Announces Its 7th Annual Cytokines And Inflammation Conference

GTCbio just announced its 7th Annual Conference on Cytokines and Inflammation scheduled for January 29-30, 2009 in Sunny San Diego, California.

Worst - 1

1
2
3
4
5

Best - 5

13.12.2008 09:00:00 - Health News from Medical News Today

Hard link

New Technology To Help Protect US Troops From Infectious Diseases: Report From NASA Scientists R

Representatives from NASA convened in New Orleans to report at the American Society of Tropical Medicine and Hygiene Annual Meeting the results from a NASA-enhanced computerized system to assess environmental and health concerns for deployed U.S. forces.

Worst - 1

1
2
3
4
5

Best - 5

13.12.2008 09:00:00 - Health News from Medical News Today

Hard link

For Short-Term Weight Loss, Economic Incentives Work

Financial incentives appear to be effective for achieving short-term weight loss, according to a study released on December 9, 2008 in JAMA. The obesity epidemic in the United States is well recognized. "In 2004, 71 percent of U.S.

Worst - 1

1
2
3
4
5

Best - 5

13.12.2008 09:00:00 - Health News from Medical News Today

Hard link

Dexamethasone Administered For Tonsillectomy Nausea And Vomiting In Children Also Increases Post-Operative Bleeding

Dexamethasone, when administered after tonsillectomies in children, is effective in reducing nausea and vomiting, but is also associated with increased risk of postoperative bleeding, according to a study released on December 9, 2008. In children, one of the most frequently performed surgical procedures is tonsillectomy.

Worst - 1

1
2
3
4
5

Best - 5

13.12.2008 09:00:00 - Health News from Medical News Today

Hard link

RAD001 Shows Promise In Tough-to-Treat Breast Cancer Patients

SAN ANTONIO - Investigators are reporting favorable early results using RAD001 (Afinitor) combined with weekly paclitaxel and trastuzumab to treat patients with HER-2 overexpressing metastatic breast cancer who have demonstrated prior resistance to trastuzumab.

Worst - 1